September 29, 2023 Sent via EmailFinancing Waiver • October 6th, 2023 • Bruush Oral Care Inc. • Dental equipment & supplies
Reference is made to that certain Securities Purchase Agreement, dated as of June 26, 2023 (the “Purchase Agreement”), between the Company and Target Capital 14, LLC (together with any of its successors and assigns, “Target”), pursuant to which the Company issued to Target a Convertible Note, in the initial principal amount of $3,341,176.00 (the “Note”) and a common stock purchase warrant to purchase 10,023,530 of the Company’s common shares, having no par value per share (the “Common Shares”). As you are aware, the Company intends to close a private placement pursuant to which the Company shall sell Common Shares and warrants to purchase Common Shares to an investor (the “Financing”).
July 18, 2024 Sent via Email Generating Alpha Ltd. Attention: Dave MartinFinancing Waiver • July 22nd, 2024 • Grom Social Enterprises, Inc. • Services-computer programming, data processing, etc.
Reference is made to (i) that certain Securities Purchase Agreement by and between the Company and Generating Alpha Ltd., a Saint Kitts and Nevis corporation (“Generating Alpha”) dated as of November 9, 2023 and amended on November 20, 2023 and March 11, 2024 (such Securities Purchase Agreement, together with all amendments, modifications, substitutions, or replacements thereof, collectively referred to as the “2023 SPA”) and (ii) that certain Securities Purchase Agreement by and between the Company and Generating Alpha dated as of April 1, 2024, as amended on April 24, 2024 (the “2024 SPA,” together with the 2023 SPA and all amendments, modifications, substitutions, or replacements thereof, collectively referred to as, the “Purchase Agreements”)
November 8, 2023 Sent via EmailFinancing Waiver • November 9th, 2023 • Bruush Oral Care Inc. • Dental equipment & supplies
Reference is made to that certain Securities Purchase Agreement, dated as of June 26, 2023 (the “Purchase Agreement”), between the Company and Target Capital 14, LLC (together with any of its successors and assigns, “Target”), pursuant to which the Company issued to Target a Convertible Note, in the initial principal amount of $3,341,176.00 (the “Note”) and a common stock purchase warrant to purchase 10,023,530 of the Company’s common shares, having no par value per share (the “Common Shares”). Capitalized terms used herein but not otherwise defined, shall have the meanings ascribed to them in the Purchase Agreement or Note, as applicable.
